deCODE genetics (Nasdaq:DCGN) today announced that it will
host a live webcast of deCODE CEO Kari Stefansson’s presentation
at the Biotechnology Industry Organization (BIO) CEO and Investor
Conference.
The presentation will be delivered at 11am EST/4pm GMT on
Monday, February 12 at the Waldorf Astoria hotel in New York.
The webcast can be accessed through the Investors page on
deCODE’s website, www.decode.com, and those interested in
listening should log on a few minutes in advance in order
to download any software or complete any sign-in that may
be required. The webcast will be archived for at least one
week.
Dr. Stefansson is also scheduled to participate in a panel
discussion at the conference entitled “The Horizon of New
Cardiovascular Drugs,” to take place at 3:30pm on February
12. The conference organizers plan to make available a webcast
of this panel discussion a few hours after the event, available
on the conference website at www.ceo.bio.org.
About
deCODE
deCODE genetics (Nasdaq:DCGN) is a global leader in applying human genetics to
develop drugs and diagnostics for common diseases. Our population approach has
enabled us to discover and target key biological pathways involved in conditions
ranging from heart attack to cancer. We are turning these discoveries into new
medicine to better treat and prevent many of the biggest challenges to public
health. deCODE is delivering on the promise of the new genetics.SM Visit us on
the web at
www.decode.com.
